Cargando…
A novel rapid detection for SARS-CoV-2 spike 1 antigens using human angiotensin converting enzyme 2 (ACE2)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), a newly emerging human infectious disease. Because no specific antiviral drugs or vaccines are available to treat COVID-19, early diagnostics, isolation, and prevention are crucial for containing...
Autores principales: | Lee, Jong-Hwan, Choi, Minsuk, Jung, Yujin, Lee, Sung Kyun, Lee, Chang-Seop, Kim, Jung, Kim, Jongwoo, Kim, Nam Hoon, Kim, Bum-Tae, Kim, Hong Gi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560266/ https://www.ncbi.nlm.nih.gov/pubmed/33099241 http://dx.doi.org/10.1016/j.bios.2020.112715 |
Ejemplares similares
-
Versatile role of ACE2-based biosensors for detection of SARS-CoV-2 variants and neutralizing antibodies
por: Lee, Jong-Hwan, et al.
Publicado: (2022) -
Manipulating angiotensin metabolism with angiotensin converting enzyme 2 (ACE2) in heart failure
por: Patel, Vaibhav B., et al.
Publicado: (2012) -
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19
por: Ni, Wentao, et al.
Publicado: (2020) -
Characterization of Angiotensin Converting Enzyme-2 (ACE2) in Human Urine
por: Lew, Rebecca A., et al.
Publicado: (2006) -
Angiotensin Converting Enzyme (ACE) and ACE2 Bind Integrins and ACE2 Regulates Integrin Signalling
por: Clarke, Nicola E., et al.
Publicado: (2012)